See how top analysts and institutions rate HIMS — including buy, hold, and sell recommendations.
| Rating Source | Action | Rating | Target Price | Updated |
|---|---|---|---|---|
| KeyBanc Capital Markets | Initiated | Sector Weight | 2025-10-21 | |
| Needham | Downgrade | Buy → Hold | 2025-06-23 | |
| Needham | Reiterated | Buy | $61 → $65 | 2025-06-04 |
| Date | Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|---|
| November 2025 | 0 | 3 | 8 | 1 | 2 |
| October 2025 | 0 | 3 | 8 | 2 | 1 |
| September 2025 | 0 | 3 | 7 | 2 | 1 |
| August 2025 | 0 | 3 | 7 | 1 | 1 |
The majority of institutional investors have issued a "Buy" rating for HIMS, and analyst sentiment aligns closely, with very few "Sell" recommendations. This suggests a broadly favorable outlook for the stock's performance.
